Global Bone Grafts and Substitutes market size is expected to reach USD 4.56 billion by 2027, analyzes DelveInsight

DelveInsight's Bone Grafts and Substitutes Market Insights report provides the current and forecast Bone Grafts and Substitutes market, upcoming device innovation, individual leading Bone Grafts and Substitutes companies market shares, challenges, drivers, barriers, and market trends and key companies in the Bone Grafts and Substitutes market.

Key Takeaways from the Global Bone Grafts and Substitutes Market

• According to DelveInsight analysis, North America is expected to dominate the overall Bone Grafts and Substitutes market during the forecast period.
• The leading Bone Grafts and Substitutes companies such as Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew, Stryker, Nuvasive Inc, Baxter, AlloSource, Orthofix Medical Inc., Musculoskeletal Transplant Foundation, Bioventus, Exactech Inc, B. Braun Melsungen AG, SeaSpine, Medtronic, Dentsply Sirona Inc. Institut Straumann AG, SOUTHERN IMPLANTS, MedBone Biomaterials, BioHorizons, NORAKER and others are actively working in the Bone Grafts and Substitutes market.
• As per DelveInsight analysis, the global Bone Grafts and Substitutes market size is expected to reach USD 4.56 billion by 2027.
• In May 2021, Prosidyan received the CE mark certifications for their fibergaft bone graft substitutes intended to be used in spinal fusion procedures.
• In March 2020, BONESUPPORT AB received the breakthrough device status for their product "CERAMANT G" by the FDA which was followed by the submission of the DeNovo application in April 2020.
• In January 2020, GreenBone Ortho received the CE mark certifications for their nature-inspired biomimetic GreenBone Bone Substitute. The product is derived from bamboo and can be shaped by surgeons to achieve the best fit in the treatment of the osseous defect.

For more insights on the bone grafts and substitutes market; download the snapshot of the key highlights: https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Bone Graft Substitutes

Bone grafts are implantable materials that are intended to promote bone healing, osseous reconstruction, and bone formation, due to their osteoinductive, osteoconductive, and osteogenic properties. Bone grafting is a surgical procedure for replacing a missing or defective bone with materials (bone graft) from a patient's body, cadavers, animals, or a different person. Bone grafts are also employed in filling bony voids in case of the absence of bones as well as providing structural stability.

There are a number of bone graft substitutes available for use in spine fusion surgery or at various phases of clinical studies. In general, these bone grafts are a synthetic or altered version of a naturally occurring product.

There is a lot of interest in creating and improving bone graft substitutes possibilities for use in lumbar spinal fusion surgical procedures in order to avoid the need to harvest the patient's own bone, potentially lowering risk and suffering and resulting in greater fusion rates.

Bone Grafts and Substitutes Market Insights
North America is expected to dominate the overall Bone Grafts and Substitutes market during the forecast period, 2022 to 2027. This can be attributed to the growing prevalence of spine-related disorders, the increasing geriatric population, coupled with other supportive factors such as increasing orthopedic surgical procedures, new product launches, are predicted to be the major influencing factors in driving the Bone Grafts and Substitutes market growth over the forecast period.

Furthermore, increasing focus on research and development activities is further expected to bolster the growth of the North American Bone Grafts and Substitutes market. For instance, in February 2020, MTF Biologics received a USD 1.8 million grant in the nation via 2019 Extramural Research Grants Program.

For further information about the scenario of the Bone Grafts and Substitutes market in other geographies, visit https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Bone Grafts and Substitutes Market Dynamics

The Bone Grafts and Substitutes market is on a rise due to a number of factors. One of the major factors driving the Bone Grafts and Substitutes market is the rising geriatric population across the globe. Rising disposable incomes and increase focus on the improvement of healthcare facilities and access across the globe have been key factors in improving the quality of life and life expectancy in general. The elderly population is susceptible to numerous bone-related disorders and degenerative bone diseases.

Moreover, the rising number of trauma cases has also contributed to the rising demand for Bone Graft Substitutes. In addition, the rising demand for dental bone grafts and an increasing number of spinal fusion procedures are also expected to drive Bone Grafts and Substitutes market growth.
However, the limitations of bone graft substitutes in the failure in the management of large bony defects, risk of infections associated with allografts, and limited osteoinductive and osteoconductive potential of synthetic bone grafts, are expected to limit the Bone Grafts and Substitutes market growth over the forecast period.

Get a sneak peek at the bone graft substitutes market dynamics https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Bone Grafts and Substitutes Market Report
• Coverage: Global
• Study Period: 2019-2027
• Market Segmentation By Bone Graft Product Type- Allografts (Demineralized Bone Matrix, Bone Morphogenetic Protein, and Cell-Based Matrices), Xenografts, and Others
• Market Segmentation by Source - Natural, Synthetic, and Others
• Market Segmentation by Application - Craniomaxillofacial, Dental, Joint Reconstruction, Spine, and Others
• Market Segmentation By End-User - Hospitals, Specialty Clinics, and Others
• Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
• Key Bone Grafts and Substitutes Companies - Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew, Stryker, Nuvasive Inc, Baxter, AlloSource, Orthofix Medical Inc., Musckuloskeletal Transplant Foundation, Bioventus, Exactech Inc, B. Braun Melsungen AG, SeaSpine, Medtronic, Dentsply Sirona Inc. Institut Straumann AG, SOUTHERN IMPLANTS, MedBone Biomaterials, BioHorizons, NORAKER, and others.
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech player in the bone grafts and substitutes market is set to emerge as the trendsetter explore @ https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Report Introduction
2. Executive summary
3. Regulatory and Patent Analysis
4. Bone Grafts and Substitutes Market Key Factors Analysis
5. Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Bone Grafts and Substitutes Market
7. Bone Grafts and Substitutes Market Layout
8. Bone Grafts and Substitutes Global Company Share Analysis - Key 3-5 Companies
9. Bone Grafts and Substitutes Market Company and Product Profiles
10. Project Approach

Learn more about the bone graft substitutes @ https://www.delveinsight.com/sample-request/bone-grafts-and-substitutes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.